Okamoto, Sho
Ureshino, Hiroshi http://orcid.org/0000-0002-5034-3699
Kawaguchi, Atsushi
Miyazono, Motoaki
Ikeda, Yuji
Kimura, Shinya
Funding for this research was provided by:
Japan Society for the Promotion of Science (19K17860, 17K09908)
Article History
Received: 11 January 2020
Revised: 2 April 2020
Accepted: 3 April 2020
First Online: 18 April 2020
Compliance with ethical standards
:
: SK has received honoraria from Bristol-Myers Squibb, Novartis, Pfizer, and Otsuka Pharmaceuticals, and research funding from Bristol-Myers Squibb, Novartis, Pfizer, Otsuka Pharmaceuticals, and Ohara Pharmaceuticals. The other authors declare no potential conflicts of interest.
: This study was approved by the Institutional Review Board of Saga University. All procedures involving human participants were performed in accordance with the ethical standards of institutional and/or national research committees, and the Declaration of Helsinki.
: Informed consent was waived because of the retrospective design of the data collection. Information of the research, including the aims of use of specimens and the opportunity to opt out from the research, was made public. No patients objected to this study.